GLP-1 potentiates post prandial insulin release when glucose levels rise after meals and reduce the gastric emptying time
These FDA-approved weight loss injections are glucagon-like peptide-1 receptor agonists, or GLP-1 RAs
Moreover, the availability of multiple effective obesity pharmacotherapies with different mechanisms of action will provide clinicians the opportunity to select treatments based on patient preference, underlying comorbidities, medication safety profile and treatment response, with an aim to achieve the individualised WL targets, improve the overall health and/or the quality of life [7]
Change in insulin resistance, beta cell function, glucagon-like peptide-1 and calcitonin levels two weeks after bariatric surgery
In addition, the ability of your body to absorb vitamin B12 from food can be hindered by certain medications, such as metformin, proton pump inhibitors, and antacids